Zhongchao Inc Cl A (ZCMD) Stock Price, Quote & News

Company Profile

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medi...

Industry: Health Information Services

Sector: Healthcare

Phone: 86 21 3220 5987

Website: www.izcmd.com

Address:

Nanxi Creative Center, Suite 216 841 Yan’An Middle Road Jing’An District, Shanghai, China

SpartanVI Jun. 25 at 10:17 AM

$ZCMD potential runner low risk 1.20s $FTRK watching where support is so far 1.90s

0 · Reply

SpartanVI Jun. 25 at 10:10 AM

$ZCMD agreed 1.3 key potential nice move above it

0 · Reply

JL_TradeZ Jun. 25 at 10:10 AM

$ZCMD starting to coil under $1.31 breakout level. Low float China biotech with a long history of 40–100% spikes off PRs. No dilution since the Feb reverse split. Volume is creeping up and MACD is curling on all timeframes. Watch closely for a breakout trigger

0 · Reply

Twentytrade Jun. 25 at 10:07 AM

$ZCMD $BLNE get. The fk out of here pro trader

0 · Reply

SpartanVI Jun. 25 at 10:06 AM

$ZCMD potential like $BLNE

0 · Reply

SpartanVI Jun. 25 at 10:05 AM

$ZCMD $NAAS $MAAS Moved several times from this area Looks ready

0 · Reply

SpartanVI Jun. 25 at 9:31 AM

$ZCMD could go like $NAAS $MAAS

0 · Reply

SpartanVI Jun. 25 at 9:28 AM

$ZCMD wants to go

0 · Reply

Breqqswings Jun. 24 at 4:31 PM

$ZCMD up down, up down this one is the last week

0 · Reply

jdlman Jun. 24 at 10:39 AM

$ZCMD no noise here

0 · Reply

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Feb 27, 2024, 8:00 AM EST - 1 year ago

Zhongchao Inc. Announces 1-for-10 Share Consolidation

Dec 11, 2023, 8:00 AM EST - 1 year ago

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Oct 23, 2023, 8:00 AM EDT - 1 year ago

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Sep 25, 2023, 8:00 AM EDT - 1 year ago

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Aug 24, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

Jul 11, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education

Jun 12, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

May 12, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

May 8, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China

Apr 24, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health

Mar 30, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction

Feb 23, 2023, 8:00 AM EST - 2 years ago

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

Feb 13, 2023, 9:20 AM EST - 2 years ago

Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency

Feb 8, 2023, 7:30 AM EST - 2 years ago

Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience

Jan 31, 2023, 7:30 AM EST - 2 years ago

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

Jan 19, 2023, 7:30 AM EST - 2 years ago

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

Jan 4, 2023, 7:30 AM EST - 2 years ago

Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited

Dec 5, 2022, 7:30 AM EST - 2 years ago

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

Nov 3, 2022, 7:30 AM EDT - 2 years ago

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

Sep 28, 2022, 9:18 AM EDT - 2 years ago

Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications

Sep 15, 2022, 7:30 AM EDT - 3 years ago

Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases

Sep 1, 2022, 7:30 AM EDT - 3 years ago

Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management

Jun 13, 2022, 6:30 AM EDT - 3 years ago

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course

May 9, 2022, 6:30 AM EDT - 3 years ago

Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results

Oct 29, 2021, 6:30 AM EDT - 3 years ago

Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment

Sep 17, 2021, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

Sep 10, 2021, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market

Aug 12, 2021, 8:30 AM EDT - 4 years ago

Zhongchao Inc. Builds A Patient DOT Management System

Jul 27, 2021, 8:30 AM EDT - 4 years ago

Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level

Jul 1, 2021, 8:30 AM EDT - 4 years ago

Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management

Jun 29, 2021, 4:39 AM EDT - 4 years ago

Zhongchao: Cheap Growth And Value Healthcare Education Stock

May 28, 2021, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management

Apr 30, 2021, 9:00 AM EDT - 4 years ago

Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results

Mar 17, 2021, 6:30 AM EDT - 4 years ago

Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline

Feb 1, 2021, 5:10 PM EST - 4 years ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm

Jan 13, 2021, 6:30 AM EST - 4 years ago

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts

Jan 11, 2021, 4:23 PM EST - 4 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zhongchao Inc. and Encourages Investors with Losses to Contact the Firm

Dec 10, 2020, 8:53 AM EST - 4 years ago

6 Health Care Stocks Trading With Low Price-Earnings Ratios

YCBD

Nov 12, 2020, 6:30 AM EST - 5 years ago

Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China

Sep 21, 2020, 9:15 AM EDT - 5 years ago

Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results

Aug 21, 2020, 6:48 AM EDT - 5 years ago

Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound Management Association (EWMA)

Aug 11, 2020, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease

Aug 4, 2020, 7:12 AM EDT - 5 years ago

Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation since 2017

SpartanVI Jun. 25 at 10:17 AM

$ZCMD potential runner low risk 1.20s $FTRK watching where support is so far 1.90s

0 · Reply

SpartanVI Jun. 25 at 10:10 AM

$ZCMD agreed 1.3 key potential nice move above it

0 · Reply

JL_TradeZ Jun. 25 at 10:10 AM

0 · Reply

Twentytrade Jun. 25 at 10:07 AM

$ZCMD $BLNE get. The fk out of here pro trader

0 · Reply

SpartanVI Jun. 25 at 10:06 AM

$ZCMD potential like $BLNE

0 · Reply

SpartanVI Jun. 25 at 10:05 AM

$ZCMD $NAAS $MAAS Moved several times from this area Looks ready

0 · Reply

SpartanVI Jun. 25 at 9:31 AM

$ZCMD could go like $NAAS $MAAS

0 · Reply

SpartanVI Jun. 25 at 9:28 AM

$ZCMD wants to go

0 · Reply

Breqqswings Jun. 24 at 4:31 PM

$ZCMD up down, up down this one is the last week

0 · Reply

jdlman Jun. 24 at 10:39 AM

$ZCMD no noise here

0 · Reply

Dreamer89 Jun. 24 at 8:53 AM

$SMTK $ZCMD $XBIO gorgeous premarket pump dumps. Banked on all 3 booooooom 😂😂😂😂

0 · Reply

LongDuckDongFever2020 Jun. 23 at 3:51 PM

$SVRE in for 15k shares on this dip. $ZCMD dip buys

0 · Reply

RollingDollars Jun. 23 at 8:16 AM

$ZCMD

0 · Reply

LongDuckDongFever2020 Jun. 23 at 1:48 AM

$ZCMD top watch early Monday for squeeze. $CISS weekly downtrend break above $4 with volume for a swing

0 · Reply

MustLoveStocks Jun. 21 at 5:55 AM

$ZCMD so few watchers here. Seems weird as a day trader how fast this rips and its lack of chat. 🤔 on my watch list for sure. Looks like great quick action when it does move and big prices previously. Worth looking at. I’ll do some research, but what do the baggers already have that could save some time? What’s the story here?

0 · Reply

RollingDollars Jun. 20 at 6:15 PM

$ZCMD

0 · Reply

RiskRewardLab Jun. 20 at 6:07 PM

$ZCMD $INLF Keep china tickers on watch for end of day. GLMD Order book is switching bullish after this consolidation. Massive bids coming in. Could close above 1.90$. GLP1 catalyst could come next week and bring this ticker to top gainers 200-500%. 5-7$ price target

0 · Reply